Back
  1. Home
  2. Profile of Angela Kvasz (ULiège)
Profil

Kvasz Angela

See author's contact details
Main Referenced Co-authors
Reginster, Jean-Yves  (7)
Bruyère, Olivier  (3)
Zegels, Brigitte  (3)
Ethgen, Olivier  (2)
Henrotin, Yves  (2)
Main Referenced Keywords
osteoarthritis (2); bone mineral density (1); diagnosis (1); estrogens (1); hormone replacement therapy (1);
Main Referenced Disciplines
Endocrinology, metabolism & nutrition (3)
General & internal medicine (3)
Public health, health care sciences & services (3)
Rheumatology (3)
Orthopedics, rehabilitation & sports medicine (1)

Publications (total 7)

The most downloaded
5 downloads
Reginster, J.-Y., & Kvasz, A. (2002). Structure-modifying drugs in osteoarthritis. Osteoporosis International, 13 (Suppl. 1), 49-SI50. https://hdl.handle.net/2268/111661

The most cited

138 citations (OpenAlex)

Sedrine, W. B., Chevallier, T., Zegels, B., Kvasz, A., Micheletti, M. C., Gelas, B., & Reginster, J.-Y. (June 2002). Development and assessment of the Osteoporosis Index of Risk (OSIRIS) to facilitate selection of women for bone densitometry. Gynecological Endocrinology, 16 (3), 245-250. doi:10.1080/gye.16.3.245.250 https://hdl.handle.net/2268/115560

Ethgen, O., Tancredi, A., Lejeune, E., Kvasz, A., Zegels, B., & Reginster, J.-Y. (November 2003). Do utility values and willingness to pay suitably reflect health outcome in hip and knee osteoarthritis? A comparative analysis with the WOMAC index. Journal of Rheumatology, 30 (11), 2452-2459.
Peer Reviewed verified by ORBi

Reginster, J.-Y., Kvasz, A., Bruyère, O., & Henrotin, Y. (February 2003). is there any rationale for prescribing hormone replacement therapy (HTR) to prevent or to treat osteoarthritis? Osteoarthritis and Cartilage, 11 (2), 87-91. doi:10.1053/joca.2002.0872
Peer Reviewed verified by ORBi

Kvasz, A., Bruyère, O., Neuprez, A., & Reginster, J.-Y. (November 2002). Is there any rationale for prescribing hormone replacement therapy (HRT) to prevent or to treat osteoarthritis? Osteoporosis International, 13 (Suppl.3), 59.
Peer Reviewed verified by ORBi

Ethgen, O., Tancredi, A., Lejeune, E., Zegels, B., Kvasz, A., & Reginster, J.-Y. (November 2002). A comparative analysis between the time trade-off and the willingness to pay approaches in hip and knee osteoarthritis. Osteoporosis International, 13 (Suppl. 3), 47.
Peer Reviewed verified by ORBi

Sedrine, W. B., Chevallier, T., Zegels, B., Kvasz, A., Micheletti, M. C., Gelas, B., & Reginster, J.-Y. (June 2002). Development and assessment of the Osteoporosis Index of Risk (OSIRIS) to facilitate selection of women for bone densitometry. Gynecological Endocrinology, 16 (3), 245-250. doi:10.1080/gye.16.3.245.250
Peer Reviewed verified by ORBi

Reginster, J.-Y., Kvasz, A., Bruyère, O., & Henrotin, Y. (2002). Glucosamine and chondroitine sulfate. In Anti Aging Medizin 2001 : Konferenz der German Society of Anti-Aging Medicine (pp. 97-104). Berlin, Germany: Congres Compact Publ.

Reginster, J.-Y., & Kvasz, A. (2002). Structure-modifying drugs in osteoarthritis. Osteoporosis International, 13 (Suppl. 1), 49-SI50.
Peer Reviewed verified by ORBi

Contact ORBi